Endometrioid Adenocarcinoma

Also known as: Endometrioid Endometrial Adenocarcinoma / Endometrial Endometrioid Adenocarcinoma / Adenocarcinoma, Endometrioid / Endometrioid carcinoma (morphologic abnormality) / Endometrioid carcinoma / Carcinoma, Endometrioid / Endometrioid carcinoma of endometrium (disorder) / Primary endometrioid carcinoma of endometrium (disorder) / Endometrial adenocarcinoma / Adenocarcinoma of uterus (disorder) / Adenocarcinoma endometrial / Adenocarcinoma of endometrium (disorder) / Uterine adenocarcinoma

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB12001	Abemaciclib	0	Recruiting	1
DB01006	Letrozole	0	Recruiting	1
DB11740	Adavosertib	1	Terminated	1
DB00062	Albumin human	1	Active Not Recruiting	1
DB17450	Albumin-stabilized nanoparticle (130 nm)	1	Active Not Recruiting	1
DB00112	Bevacizumab	1	Active Not Recruiting	1
DB00958	Carboplatin	1	Completed	1
DB14547	Chloride ion	1	Terminated	1
DB00515	Cisplatin	1	Terminated	1
DB01254	Dasatinib	1	Completed	1
DB17563	Luveltamab tazevibulin	1	Recruiting	1
DB01229	Paclitaxel	1	Active Not Recruiting	1
DB01229	Paclitaxel	1	Completed	1
DB12257	Platinum	1	Terminated	1
DB12218	Capivasertib	2	Active Not Recruiting	1
DB04849	Cediranib	2	Active Not Recruiting	1
DB12483	Copanlisib	2	Completed	1
DB15627	Dostarlimab	2	Not Yet Recruiting	1
DB11714	Durvalumab	2	Active Not Recruiting	1
DB06186	Ipilimumab	2	Active Not Recruiting	1
DB06186	Ipilimumab	2	Recruiting	1
DB09035	Nivolumab	2	Active Not Recruiting	1
DB09035	Nivolumab	2	Recruiting	1
DB09035	Nivolumab	2	Terminated	1
DB09074	Olaparib	2	Active Not Recruiting	1
DB12332	Rucaparib	2	Terminated	1
DB01268	Sunitinib	2	Completed	1
DB00958	Carboplatin	3	Active Not Recruiting	1
DB01229	Paclitaxel	3	Active Not Recruiting	1
DB09037	Pembrolizumab	3	Active Not Recruiting	2